What is the definition of Splenomegaly?

Splenomegaly is a larger-than-normal spleen. The spleen is an organ in the upper left part of the belly.

What are the alternative names for Splenomegaly?

Spleen enlargement; Enlarged spleen; Spleen swelling

CONSIDERATIONS

The spleen is an organ that is a part of the lymph system. The spleen filters the blood and maintains healthy red and white blood cells and platelets. It also plays a role in immune function.

Many health conditions can affect the spleen. These include:

  • Diseases of the blood or lymph system
  • Infections
  • Cancer
  • Liver disease

Symptoms of splenomegaly include:

  • Hiccups
  • Inability to eat a large meal
  • Pain in the upper left side of the belly

What are the causes for Splenomegaly?

Splenomegaly can be caused by any of the following:

  • Infections
  • Liver diseases
  • Blood diseases
  • Cancer

HOME CARE

In rare cases, an injury can rupture the spleen. If you have splenomegaly, your health care provider may advise you to avoid contact sports. Your provider will tell you what else you need to do to take care of yourself and any medical condition.

When should I contact a medical professional for Splenomegaly?

There are usually no symptoms from an enlarged spleen. Seek medical help right away if pain in your belly is severe or gets worse when you take a deep breath.

WHAT TO EXPECT AT YOUR OFFICE VISIT

The provider will ask about your symptoms and medical history.

A physical exam will be done. The provider will feel and tap along the upper left part of your belly, especially just under the rib cage.

Tests that may be done include:

  • Abdominal x-ray, ultrasound, or CT scan
  • Blood tests, such as a complete blood count (CBC) and tests of your liver function

Treatment depends on the cause of splenomegaly.

Splenomegaly
Enlarged

REFERENCES

Winter JN. Approach to the patient with lymphadenopathy and splenomegaly. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 159.

Vos PM, Barnard SA, Cooperberg PL. Benign and malignant lesions of the spleen. In: Gore RM, Levine MS, eds. Textbook of Gastrointestinal Radiology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2015:chap 105.

Vos PM, Mathieson JR, Cooperberg PL. The spleen. In: Rumack CM, Levine D, eds. Diagnostic Ultrasound. 5th ed. Philadelphia, PA: Elsevier; 2018:chap 5.

  • Condition: Newly Diagnosed Patients with Chronic Myeloid Leukemia in the Chronic Phase (CML-CP)
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Imatinib as Front-Line Therapy
  • Number of Patients: 957
  • Published —
This study explored the characteristics, treatment, and outcomes in newly diagnosed patients with chronic myeloid leukemia in the chronic phase (CML-CP).
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 23
  • Start Date: May 21, 2021
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 12
  • Start Date: May 3, 2021
Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia